Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information
August 09, 2016 16:20 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2016 and Provides Conference Call Information
June 15, 2016 16:19 ET
|
Elite Pharmaceuticals, Inc.
Revenues Increased 150% Conference Call Scheduled for Monday, June 20 at 11:00 AM EDT NORTHVALE, N.J., June 15, 2016 ...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
February 05, 2016 12:42 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
September 02, 2015 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCQB:ELTP) a specialty pharmaceutical company which manufactures and sells niche generic products and is developing a...
Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules
January 15, 2015 10:46 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015
November 18, 2014 18:24 ET
|
Elite Pharmaceuticals, Inc.
Revenues increase by 8%
Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST
NORTHVALE, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the...
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, November 19, 2014
November 13, 2014 17:02 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals Announces New Management Appointments
October 24, 2014 07:15 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP),a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
September 03, 2014 13:47 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP) a specialty pharmaceutical company developing a pipeline of pharmacological abuse deterrent opioids with...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015
August 14, 2014 16:14 ET
|
Elite Pharmaceuticals, Inc.
Revenues Increase by 61%, Product Development on Schedule
Conference Call Scheduled for Monday, August 18th at 11:00 AM EDT
NORTHVALE, N.J., Aug. 14, 2014 (GLOBE NEWSWIRE) -- Elite...